These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6202703)

  • 21. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis.
    Yeldandi AV; Milano M; Subbarao V; Reddy JK; Rao MS
    Cancer Lett; 1989 Sep; 47(1-2):21-7. PubMed ID: 2636030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator.
    Rao MS; Subbarao V
    Cancer Lett; 1995 Nov; 97(2):185-8. PubMed ID: 7497461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1993 Dec; 46(12):2219-27. PubMed ID: 8274155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
    Rao MS; Dwivedi RS; Subbarao V; Reddy JK
    Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic effects of a new hypolipidemic agent, ciprofibrate.
    Arnold A; McAuliff MP; Beyler AL
    J Pharm Sci; 1979 Dec; 68(12):1557-8. PubMed ID: 529054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.
    Glauert HP; Clark TD
    Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate.
    Yang JH; Kostecki PT; Calabrese EJ; Baldwin LA
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):476-82. PubMed ID: 2385837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroepiandrosterone inhibits DNA synthesis of rat hepatocytes induced by partial hepatectomy or mitogen (ciprofibrate).
    Rao MS; Subbarao V
    Cell Prolif; 1997 Jan; 30(1):1-5. PubMed ID: 9332491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents.
    Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N
    Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver.
    Lalwani ND; Alvares K; Reddy MK; Reddy MN; Parikh I; Reddy JK
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5242-6. PubMed ID: 3474650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in the hepatic response to a potent peroxisome proliferator.
    Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
    Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
    [No Abstract]   [Full Text] [Related]  

  • 33. Transdifferentiated hepatocytes in rat pancreas.
    Rao MS; Scarpelli DG; Reddy JK
    Curr Top Dev Biol; 1986; 20():63-78. PubMed ID: 3082602
    [No Abstract]   [Full Text] [Related]  

  • 34. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
    Perrone CE; Williams GM
    Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of peroxisomal enzymes in cultured porcine endothelial cells by the hypolipidemic drug ciprofibrate.
    Glauert HP; Hennig B; Chow HS
    J Biochem Toxicol; 1990; 5(2):115-8. PubMed ID: 2283660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
    Hong JT; Wilson MW; Glauert HP
    J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
    Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
    Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood.
    Lupp A; Karge E; Danz M; Deufel T; Oelschläger H; Klinger W
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):203-18. PubMed ID: 16250258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
    Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
    Li Y; Leung LK; Glauert HP; Spear BT
    Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.